ENVALITH
扶桑薬品工業株式会社 logo

Fuso Pharmaceutical Industries, Ltd.

4538Prime MarketPharmaceuticals

扶桑薬品工業株式会社 logo
Fuso Pharmaceutical Industries, Ltd.4538

Governance

The company is structured as a company with a Board of Corporate Auditors, comprising 8 directors (of which 3 are outside directors, an outside ratio of 37.5%). All outside directors and outside corporate auditors are designated as independent officers. A voluntary Compensation Committee has been established, and an executive officer system has also been introduced.

Outside Director Ratio

37.5%

Nomination Committee

Not Established

Compensation Committee

Established

Risk Management

The Risk Management Committee, chaired by the Representative Director and President, together with the Management Meeting, identifies and evaluates company-wide risks and formulates response policies. Climate change and human rights risks are overseen by the Sustainability Committee, which is advancing measures linked to 1.5°C and 4°C scenario analyses and the Business Continuity Plan (BCP).

Shareholder Returns

The basic policy is to pay dividends twice a year (interim and year-end). For FY2026 (ending March 2026), a total of ¥90 per share (¥45 interim + ¥45 year-end) was implemented, with a payout ratio of 38.2%. For FY2027 (ending March 2027), an annual dividend of ¥90 (¥45 × 2) is also planned. Share buybacks are also being continued.

Dividend Policy

The basic policy is to pay continuous and stable dividends while ensuring sufficient internal reserves, with dividends paid twice a year through interim and year-end dividends. For FY2026 (ending March 2026), an interim dividend of ¥45 and a year-end dividend of ¥45 (totaling ¥90) were implemented, with total dividends of ¥768 million and a payout ratio of 38.2%. For FY2027 (ending March 2027), an annual dividend of ¥90 (¥45 interim and ¥45 year-end) is also planned.

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

The company targets a reduction of GHG emissions (Scope 1 and 2) by at least 30% by FY2030 (compared to FY2013 levels) and net zero by FY2050, and formulated a human rights policy in FY2025. In terms of human capital, it has set targets for FY2030 of a 10% ratio of female managers, 100% rate of male employees taking childcare leave, and a 3.0% employment rate for persons with disabilities, with the Sustainability Committee promoting these initiatives under the oversight of the Board of Directors.

Last updated: June 23, 2026